CD 4+ T cells in the pathobiology of neurodegenerative disorders.
about
Regulatory T cells in CNS injury: the simple, the complex and the confusedLeukocyte-subset counts in idiopathic parkinsonism provide clues to a pathogenic pathway involving small intestinal bacterial overgrowth. A surveillance study.Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson's Disease.HIV-1 neuroimmunity in the era of antiretroviral therapy.High frequency of CD4+ CXCR5+ TFH cells in patients with immune-active chronic hepatitis BDifferential effect of Helicobacter pylori eradication on time-trends in brady/hypokinesia and rigidity in idiopathic parkinsonism.Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders.TLR2-dependent modulation of dendritic cells by LT-IIa-B5, a novel mucosal adjuvant derived from a type II heat-labile enterotoxin.Selective VIP Receptor Agonists Facilitate Immune Transformation for Dopaminergic Neuroprotection in MPTP-Intoxicated Mice.Eosinophil-derived neurotoxin is elevated in patients with amyotrophic lateral sclerosis.Role of regulatory T cell in clinical outcome of traumatic brain injury.Blood profile holds clues to role of infection in a premonitory state for idiopathic parkinsonism and of gastrointestinal infection in established diseaseNeurodegenerative disorders and nanoformulated drug development.NanoART, neuroAIDS and CNS drug delivery.A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection.Progenitor cells: therapeutic targets after traumatic brain injury.Peripheral leukocyte populations and oxidative stress biomarkers in aged dogs showing impaired cognitive abilities.The Neuroinflammatory Response in ALS: The Roles of Microglia and T Cells.Parkinson's disease and systemic inflammation.Biochemical and immunological aspects of protein aggregation in neurodegenerative diseases
P2860
Q30424827-6CD9B023-A77E-4DF9-A774-93592B8AAC09Q30528442-73523323-81B8-47F1-A80E-790F3306D9B9Q31109638-D1480D1D-0659-4374-8208-CB3161BE407CQ33733529-A1444DCD-E360-416D-88C3-B83E94BD9FECQ33959352-E0D6DA62-198D-4396-BAA8-2E2F1D7D305FQ34032330-6EACDF0F-49A4-45BF-9DC6-2C4745E6CC1EQ35068792-13C6A562-59EE-4FA0-95D2-E2AADE21AAEBQ35505233-8E7A470C-E72A-4583-969D-B5F9EA378191Q36373813-00F90B0D-A491-4F04-8712-7F56E888E3FFQ36663923-890A488E-8DF4-4626-8650-46C0AFDC1B3CQ36801440-0946EAA4-598D-43CF-A0A7-62BCF0409EF1Q37483107-83E77A4A-EAC9-4C12-A72A-48BA001661EFQ37538771-C7A06033-BF27-4802-B3DB-55E88620DF4AQ37538776-0C110DD4-AAB4-47D1-9C23-98275FA8D5DAQ37617639-2F15DCDD-063E-46E6-9B47-14CAB8C96E74Q38170059-4C761BAF-A669-451D-9006-F357DAE8B941Q39919240-1A9595AE-9D74-4B3F-9CB7-B1AD2BFB1E06Q42180223-366A062A-31A3-4A24-82E7-2ADB603D001CQ42651923-2CC79639-EBAE-4D10-9994-914366F08EBBQ57405353-270F86B7-B7B9-4940-BC16-89F2D09E300E
P2860
CD 4+ T cells in the pathobiology of neurodegenerative disorders.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CD 4+ T cells in the pathobiology of neurodegenerative disorders.
@en
CD 4+ T cells in the pathobiology of neurodegenerative disorders.
@nl
type
label
CD 4+ T cells in the pathobiology of neurodegenerative disorders.
@en
CD 4+ T cells in the pathobiology of neurodegenerative disorders.
@nl
prefLabel
CD 4+ T cells in the pathobiology of neurodegenerative disorders.
@en
CD 4+ T cells in the pathobiology of neurodegenerative disorders.
@nl
P2093
P2860
P1476
CD 4+ T cells in the pathobiology of neurodegenerative disorders.
@en
P2093
Ashley D Reynolds
Howard E Gendelman
R Lee Mosley
Xiuyan Huang
P2860
P356
10.1016/J.JNEUROIM.2009.04.006
P577
2009-05-12T00:00:00Z